¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦42Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2023-06-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦42Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2023-06-23
±³À°ÀÏÀÚ : 2023-06-23
±³À°Àå¼Ò : ºÎ»ê BEXCO ÄÁº¥¼ÇȦ 1F, 2F

±³À°ÁÖÁ¦ : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦42Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : Á¶¿¹¸®
¿¬¶ôó : 02-582-8222  

À̸ÞÀÏ : yehc@kscvi.org

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 21 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í - Àü¹®ÀÇ,°³¿øÀÇ,ÀϹÝÀÇ:(ÇöÀåµî·Ï)60,000¿ø - ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç,ÀÇ·á±â»ç,ÀÇ´ë»ý,±ºÀÇ°ü,°øÁߺ¸°ÇÀÇ,ÀÓ»óº´¸®»ç,Àǹ«±â·Ï»ç:(ÇöÀåµî·Ï)50,000¿ø - »ê¾÷ü,±âŸ:(ÇöÀåµî·Ï)120,000¿ø - ÇÐȸ Á¤È¸¿ø(Àü³âµµ ȸºñ¿Ï³³ÀÚ): ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 09:00~09:13 (Ãʷϱ¸¿¬¹ßÇ¥) How to Do Imaging Guided PCI(Percutaneous Coronary Intervention) in LM(Left Main) ¾ÈÁ¤¹Î(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 09:13~09:26 (Ãʷϱ¸¿¬¹ßÇ¥) What Is My Preference: IVUS(Intravascular Ultrasonography) or OCT(Optical Coherence Tomography)? È«¼øÁØ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 09:26~09:39 (Ãʷϱ¸¿¬¹ßÇ¥) Deep Dive into RENOVATE Complex PCI(Percutaneous Coronary Intervention) Trial ÇÑÁÖ¿ë(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 09:39~09:52 (Ãʷϱ¸¿¬¹ßÇ¥) How to Optimize Angio (QCA) Guided PCI(Percutaneous Coronary Intervention)? ÀÌöȯ(¿ï»êÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Main Arena 09:52~10:00 Discussion ()

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 09:00~09:10 (Ãʷϱ¸¿¬¹ßÇ¥) Cholesterol and Statin ±èº´±Ø(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 09:10~09:20 (Ãʷϱ¸¿¬¹ßÇ¥) Life-style Modification: How to Do and How Much? ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 09:20~09:30 (Ãʷϱ¸¿¬¹ßÇ¥) Preparation for Minor and Major Surgery ±èÃæ±â(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 09:30~09:40 (Ãʷϱ¸¿¬¹ßÇ¥) Fact Sheet: What Is the Real World Clinical Outcome after PCI(Percutaneous Coronary Intervention)? °­ÁöÈÆ(¼­¿ïÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Symposium Arena 09:40~10:00 Discussion ()

ÈÞ½Ä 06¿ù 23ÀÏ 10:00~10:05 Break ()

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 10:05~10:18 (Ãʷϱ¸¿¬¹ßÇ¥) Lifetime Treatment after TAVR(Transcatheter Aortic Valve Replacement): BEV(Balloon-expandable valves) vs. SEV(Self-expandable valves) ±è¿õ(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 10:18~10:31 (Ãʷϱ¸¿¬¹ßÇ¥) Coronary Rescue for Valve-in-Valve Procedure: Step-by-Step Basilica Technique Àå±âÀ°(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 10:31~10:44 (Ãʷϱ¸¿¬¹ßÇ¥) The Role of TAVR(Transcatheter Aortic Valve Replacement) in Pure AR(Aortic Regurgitation) À¯Ã¶¿õ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 10:44~10:57 (Ãʷϱ¸¿¬¹ßÇ¥) How to Manage in Asymptomatic Severe AS(Aortic Stenosis) ±èÀº°æ(¼º±Õ°üÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Main Arena 10:57~11:05 Discussion ()

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 10:05~10:15 (Ãʷϱ¸¿¬¹ßÇ¥) CABG(Coronary Artery Bypass Grafting) Á¤µ¿¼·(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 10:15~10:25 (Ãʷϱ¸¿¬¹ßÇ¥) Aortic Valve and Aorta Surgery Á¦Çü°ï(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 10:25~10:35 (Ãʷϱ¸¿¬¹ßÇ¥) Mitral Valve, MAZE, and LAA(Left Atrial Appendage) Occlusion À¯Àç¼®(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 10:35~10:45 (Ãʷϱ¸¿¬¹ßÇ¥) Peripheral Artery Surgery ±èÇü±â(°æºÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 10:45~10:55 (Ãʷϱ¸¿¬¹ßÇ¥) Pulmonary Thromboembolectomy ±èÈ£Áø(¿ï»êÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Symposium Arena 10:55~11:05 Discussion ()

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 10:05~10:20 (Ãʷϱ¸¿¬¹ßÇ¥) Why Intravascular Imaging Should Be Used in Clinical Practice, Review from Evidence ±è¼öÁß(°æÈñÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 10:20~10:35 (Ãʷϱ¸¿¬¹ßÇ¥) How to Set Up and Use of Intravascular Imaging for Acquiring Good Image of IVUS(Intravascular Ultrasonography) and OCT(Optical Coherence Tomography) ±è¿ëö(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 10:35~10:50 (Ãʷϱ¸¿¬¹ßÇ¥) How to Optimize the Stented Segment, Review of Recent Expert Consensus for the Use of Intravascular Imaging ¼Û¿µºó(¼º±Õ°üÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Seminar Room 10:50~11:05 Discussion ()

ÈÞ½Ä 06¿ù 23ÀÏ 11:05~11:10 Break ()

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 11:10~11:55 Themed Issue-1: Representative PCI(Percutaneous Coronary Intervention) Case Show (Case #1: Left Main Bifurcation) ÁøÇÑ¿µ(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 11:55~12:40 Themed Issue-1: Representative PCI(Percutaneous Coronary Intervention) Case Show (Case #2: Calcified Long Lesion) ÀåÀç½Ä(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 11:10~11:30 Optimal Antiplatelet treatment in ACS(Acute Coronary Syndrome) patients ÀÌÀåÈÆ(°æºÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 11:30~11:50 Rivaroxaban for preventing atherothrombotic events in patients with coronary or peripheral artery disease ±èÁß¼±(¿¬¼¼ÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Seminar Room 11:50~12:10 Discussion ()

ÈÞ½Ä 06¿ù 23ÀÏ 12:40~12:45 Break ()

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 12:45~13:10 Achieving Target Blood Pressure with Fimasartan Combination Therapy Á¶À±°æ(°è¸íÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 13:10~13:35 Comprehensive Treatment Options for Patients with 2nd stage HTN(Hypertension) & Dyslipidemia À̽ÂÁØ(¿¬¼¼ÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Main Arena 13:35~13:45 Q&A ()

±âŸ 06¿ù 23ÀÏ Symposium Arena 12:45~13:47 Session Intro ()

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 12:45~13:00 (Ãʷϱ¸¿¬¹ßÇ¥) Recent Updates for Evidence of Staged Complete and Immediate Complete PCI(Percutaneous Coronary Intervention) with Ultrathin Strut: BIOVASC Á¶Á¤·¡(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 13:00~13:15 (Ãʷϱ¸¿¬¹ßÇ¥) Case I Manage Patients with Staged Complete PCI(Percutaneous Coronary Intervention) Á¶¼º¼ö(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 13:15~13:30 (Ãʷϱ¸¿¬¹ßÇ¥) Case I Manage Patients with Immediate Complete PCI(Percutaneous Coronary Intervention) ¹®ÀÎÅÂ(À»ÁöÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Symposium Arena 13:30~13:45 Discussion ()

±âŸ 06¿ù 23ÀÏ Symposium Arena 13:42~13:45 Closing ()

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 12:45~13:00 (Ãʷϱ¸¿¬¹ßÇ¥) New concepts of Dyslipidemia Medication : the Lower, the Smaller ±è»óÇö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 13:00~13:15 (Ãʷϱ¸¿¬¹ßÇ¥) FDC Management of Hypertension and Dyslipidemia ±è¼ÛÀÌ(Á¦ÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 13:15~13:30 (Ãʷϱ¸¿¬¹ßÇ¥) Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors? ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Seminar Room 13:30~13:45 Discussion ()

±âŸ 06¿ù 23ÀÏ Main Arena 13:45~14:00 2023³â ¹Ì·¡±¹¹Î°Ç°­Æ÷·³ ÇмúÁøÈï»ó ½Ã»ó ()

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 14:00~14:25 (Ãʷϱ¸¿¬¹ßÇ¥) RENOVATE-COMPLEX-PCI(Percutaneous Coronary Intervention) ¿¬±¸: Çè³­Çß´ø NEJM(The New England Journal of Medicine)±îÁöÀÇ °úÁ¤ ÀÌÁÖ¸í(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 14:25~14:50 (Ãʷϱ¸¿¬¹ßÇ¥) LODESTAR ¿¬±¸: ¼º°øÀûÀÎ ºñ¿­µî ¿¬±¸ ¼öÇàÀÇ ºñ¹ý ÀÌ¿ëÁØ(¿¬¼¼ÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Main Arena 14:50~15:00 Discussion ()

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 14:00~14:10 (Ãʷϱ¸¿¬¹ßÇ¥) ÀÇ·áºÐÀï, À¯ÀÇÇØ¾ß ÇÒ »çÇ×µé ÃÖö¿õ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 14:10~14:20 (Ãʷϱ¸¿¬¹ßÇ¥) ¹æ»ç¼± ¾ÈÀü°ü¸® ¹æ¹ý ÀÌ»ó¿±(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 14:20~14:50 º¸°Çº¹ÁöºÎ ÇʼöÀÇ·áÁ¤Ã¥ ¼Ò°³ ÀÓÇý¼º(º¸°Çº¹ÁöºÎ)

Åä·Ð 06¿ù 23ÀÏ Symposium Arena 14:50~15:00 Discussion ()

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 14:00~14:20 Latest Trends in Dyslipidemia Management for Very High-risk ASCVD(Atherosclerotic Cardiovascular Disease) Patients ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 14:20~14:40 Early and High-intensity LLT(Lipid-lowering Therapy) in Very High-risk ASCVD(Atherosclerotic Cardiovascular Disease) Patients with Dyslipidemia ÀÌ¿øÀç(¼­¿ïÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Seminar Room 14:40~15:00 Discussion ()

ÈÞ½Ä 06¿ù 23ÀÏ 15:00~15:05 Break ()

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 15:05~16:05 Themed Issue-2: Representative TAVR(Transcatheter Aortic Valve Replacement) Case Show (Case: Bicuspid AS) ¾çÅÂÇö(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 15:05~15:15 (Ãʷϱ¸¿¬¹ßÇ¥) Basic Technique for EVAR(Endovascular aneurysm repair) - Sizing and Preparation ¹ÚÅñÔ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 15:15~15:25 (Ãʷϱ¸¿¬¹ßÇ¥) EVAR(Endovascular Aneurysm Repair) for AAA(Abdominal Aortic Aneurysm) with Common Iliac & Internal Iliac Aneurysm À̽ÂÁØ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 15:25~15:35 (Ãʷϱ¸¿¬¹ßÇ¥) Overcoming for Hostile Neck & Tortuosity °­¿õö(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 15:35~15:45 (Ãʷϱ¸¿¬¹ßÇ¥) Management of Type II Endoleak for Various Condition ±ÇÁØÈ£(¿¬¼¼ÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Symposium Arena 15:45~16:05 Discussion ()

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 15:05~15:20 (Ãʷϱ¸¿¬¹ßÇ¥) How to Report Coronary CT Angiography Using CAD-RAD(Coronary Artery Disease Reporting and Data System) Reporting System ½Å»óÈÆ(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 15:20~15:35 (Ãʷϱ¸¿¬¹ßÇ¥) How to Interpret Coronary CT Angiography Findings of Stenosis as a Cardiologist? ¹ÚÇüº¹(°¡Å縯°üµ¿ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 15:35~15:50 (Ãʷϱ¸¿¬¹ßÇ¥) Beyond Stenosis: Other Key Factors to Consider on Coronary CT Angiography ÀÌ»óÀº(ÀÌÈ­ÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Seminar Room 15:50~16:05 Discussion ()

ÈÞ½Ä 06¿ù 23ÀÏ 16:05~16:10 Break ()

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 16:10~16:27 (Ãʷϱ¸¿¬¹ßÇ¥) ¿¬±¸¿Í ³í¹® ÀÛ¼º¿¡ ÀÖ¾î ChatGPT µî AI ±â¼úÀÇ ¿Ã¹Ù¸¥ È°¿ë¹ý ÀÓÁؼ­(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 16:27~16:44 (Ãʷϱ¸¿¬¹ßÇ¥) ³úµ¿¸Æ·ù À§ÇèȯÀÚ ¿¹Ãø ±èÅñÕ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 16:44~17:01 (Ãʷϱ¸¿¬¹ßÇ¥) AI¸¦ ÀÌ¿ëÇÑ °ü»óµ¿¸ÆÁ¶¿µ¼ú ºÐ¼® ¼Û±³¼®(Medipixel)

Åä·Ð 06¿ù 23ÀÏ Main Arena 17:01~17:10 Discussion ()

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 16:10~16:22 (Ãʷϱ¸¿¬¹ßÇ¥) Failed Transcatheter Edge to Edge Repair (TEER) for Mitral Regurgitation; Why? How to Overcome? °­µµÀ±(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 16:22~16:34 (Ãʷϱ¸¿¬¹ßÇ¥) TEER(Transcatheter Edge to Edge Repair) for MR(Mitral Regurgitation) Using Pascal Device Molly Szerlip(Baylor Scott & White The Heart Hospital Plano. USA)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 16:34~16:46 (Ãʷϱ¸¿¬¹ßÇ¥) Transcatheter Mitral Valve Annuloplasty; Where Are We? ±èÁØÈ«(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 16:46~16:58 (Ãʷϱ¸¿¬¹ßÇ¥) TEER(Transcatheter Edge to Edge Repair) for Tricuspid Regurgitation; When and How? Anita Asgar(Montreal Heart Institute. Canada)

Åä·Ð 06¿ù 23ÀÏ Symposium Arena 16:58~17:10 Discussion ()

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 16:10~16:25 (Ãʷϱ¸¿¬¹ßÇ¥) History of Coronary Angiography and Angioplasty: How We Began? Àü±¹Áø(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 16:25~16:40 (Ãʷϱ¸¿¬¹ßÇ¥) History of Intravascular Imaging and Developing Concept of Imaging Guided Procedural Optimization È«¿µÁØ(Àü³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Seminar Room 16:40~16:55 (Ãʷϱ¸¿¬¹ßÇ¥) History of Coronary Physiology: Past, Present, and Future ³²Ã¢¿í(°è¸íÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Seminar Room 16:55~17:10 Discussion ()

ÈÞ½Ä 06¿ù 23ÀÏ 17:10~17:15 Break ()

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 17:15~17:28 (Ãʷϱ¸¿¬¹ßÇ¥) When & Why Do We Catheterize? - From History to the Present ÀüÀº¼®(´ëÇ׺´¿ø)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 17:28~17:41 (Ãʷϱ¸¿¬¹ßÇ¥) RHC(Right hemi colectomy) & LHC(Left hemi colectomy), Technique & Interpretation Ȳ¼®Àç(°æ»óÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 17:41~17:54 (Ãʷϱ¸¿¬¹ßÇ¥) Cardiac Cath in Cardiac Disease ¾çÁ¤ÈÆ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Main Arena 17:54~18:07 (Ãʷϱ¸¿¬¹ßÇ¥) Cardiac Cath in Pulmonary & Liver Disease ÀåÇ×Á¦(ÀÎÁ¦ÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Main Arena 18:07~18:15 Discussion ()

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 17:15~17:25 (Ãʷϱ¸¿¬¹ßÇ¥) Lets Focus on High-risk PFO(Patent Foramen Ovale) °­¿õö(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 17:25~17:35 (Ãʷϱ¸¿¬¹ßÇ¥) How to Perform Optimal Closure for Complex PFO(Patent Foramen Ovale) ±èÁß¼±(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 17:35~17:45 (Ãʷϱ¸¿¬¹ßÇ¥) Duration of Medication after Closure - Single or Dual Antiplatelet? ¹ÚÀçÇü(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ Symposium Arena 17:45~17:55 (Ãʷϱ¸¿¬¹ßÇ¥) Hot Issues of ASD(Atrial Septal Defect) Closure - Elderly, Size, Diastolic Dysfunction ±èÅ¿À(¿ï»êÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ Symposium Arena 17:55~18:15 Discussion ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦42Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2023-06-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Àå±âÀÌ½Ä 1000·Ê ±â³ä ÇѾç´ëÇб³º´¿ø-´ëÇÑÀ̽ÄÇÐȸ Àå±âÀÌ½Ä °øµ¿ ½ÉÆ÷Áö¾ö : 2023-06-23
´ÙÀ½±Û ´ëÇѽŻý¾ÆÇÐȸ È£³²Áöȸ ½ÉÃÊÀ½ÆÄ ¿¬¼ö°­Á : 2023-06-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 29 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 28 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 33 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 40 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 30 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 23 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 8 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 9 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 18 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 12 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 9 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 25 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 13 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 21 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 17 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷